MGTA · Categories · Form 4

MGTA - SEC Form 4 insider transactions

Magenta Therapeutics Inc. (MGTA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for MGTA

• 821d
  SEC Form 4 filed by Carr Edward

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 821d
  SEC Form 4 filed by Veness Adam M

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 821d
  SEC Form 4 filed by Randhawa Simrat

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 821d
  SEC Form 4 filed by Savitz Ryan

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 821d
  SEC Form 4 filed by Garcia Marino

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 823d
  Moulder Leon O Jr was granted 166,667 shares (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 823d
  Fairmount Funds Management Llc was granted 834,334 shares (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 823d
  Meng Lei was granted 1,500,000 shares (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 956d
  SEC Form 4 filed by Meng Lei

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 956d
  SEC Form 4 filed by Violin Jonathan

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 956d
  SEC Form 4: Fairmount Funds Management Llc bought $271,680 worth of shares (24,254 units at $11.20)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 956d
  SEC Form 4 filed by Lawton Alison Frances

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 956d
  SEC Form 4 filed by Soteropoulos Paula

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 956d
  SEC Form 4 filed by Mcgeorge Anne

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 956d
  SEC Form 4 filed by Moulder Leon O Jr

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 1172d
  SEC Form 4: Third Rock Ventures Iv, L.P. sold $3,056,000 worth of shares (3,700,000 units at $0.83)

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1241d
  SEC Form 4: Beetham Thomas W. was granted 3,000 shares, increasing direct ownership by 18% to 19,897 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1241d
  SEC Form 4: Mahoney Stephen F. was granted 3,000 shares, increasing direct ownership by 21% to 17,264 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1241d
  SEC Form 4: Deardorf Caren was granted 3,000 shares, increasing direct ownership by 18% to 19,762 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1241d
  SEC Form 4: Gardner Jason was granted 3,000 shares, increasing direct ownership by 1% to 292,872 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1241d
  SEC Form 4: Stants Kristen was granted 3,000 shares, increasing direct ownership by 17% to 20,264 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1349d
  SEC Form 4 filed by Vasconcelles Michael

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1364d
  SEC Form 4 filed by Olson Lisa

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1364d
  SEC Form 4 filed by Humphrey Jeffrey

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1364d
  SEC Form 4 filed by Beetham Thomas W.

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1364d
  SEC Form 4 filed by Gardner Jason

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1364d
  SEC Form 4 filed by Nichols David Wayne

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1364d
  SEC Form 4 filed by Mahoney Stephen F.

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1364d
  SEC Form 4 filed by Stants Kristen

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1364d
  SEC Form 4 filed by Deardorf Caren

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1396d
  SEC Form 4 filed by Booth Bruce

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1396d
  SEC Form 4 filed by Daniel Thomas O

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1396d
  SEC Form 4 filed by Lawton Alison Frances

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1396d
  SEC Form 4 filed by Ronneberg Amy L

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1396d
  SEC Form 4 filed by Albers Jeffrey W.

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1396d
  SEC Form 4 filed by Scadden David

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1396d
  SEC Form 4 filed by Mcgeorge Anne

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1420d
  SEC Form 4: Stants Kristen was granted 3,000 shares, increasing direct ownership by 21% to 17,264 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1420d
  SEC Form 4: Gardner Jason was granted 3,000 shares, increasing direct ownership by 1% to 289,872 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1420d
  SEC Form 4: Deardorf Caren was granted 3,000 shares, increasing direct ownership by 22% to 16,762 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1420d
  SEC Form 4: Beetham Thomas W. was granted 3,000 shares, increasing direct ownership by 22% to 16,897 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1438d
  SEC Form 4 filed by Olson Lisa

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1438d
  SEC Form 4 filed by Gardner Jason

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1438d
  SEC Form 4 filed by Humphrey Jeffrey

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1438d
  SEC Form 4 filed by Stants Kristen

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1438d
  SEC Form 4 filed by Nichols David Wayne

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1438d
  SEC Form 4 filed by Mahoney Stephen F.

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1438d
  SEC Form 4 filed by Beetham Thomas W.

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1438d
  SEC Form 4 filed by Deardorf Caren

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1529d
  SEC Form 4 filed by Gardner Jason

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1529d
  SEC Form 4 filed by Humphrey Jeffrey

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1529d
  SEC Form 4 filed by Stants Kristen

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1529d
  SEC Form 4 filed by Deardorf Caren

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1529d
  SEC Form 4 filed by Nichols David Wayne

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1529d
  SEC Form 4 filed by Olson Lisa

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1529d
  SEC Form 4 filed by Mahoney Stephen F.

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1529d
  SEC Form 4 filed by Beetham Thomas W.

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1665d
  SEC Form 4 filed by Humphrey Jeffrey

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1676d
  SEC Form 4 filed by Borisy Alexis

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1679d
  SEC Form 4: Stants Kristen sold $38,603 worth of Common Stock (5,736 units at $6.73), decreasing direct ownership by 29% to 14,264 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)

Other MGTA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends